Recursion Pharmaceuticals, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Rok finansowy 2020 2020 2020 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025
Kwartał Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1
Data 2020-03-31 2020-06-30 2020-09-30 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 0 0 1 3 2 2 2 2 5 8 13 14 12 11 10 11 14 14 26 5 15
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 4066.7% 1244.1% 190.0% -2.00% 112.0% 206.1% 422.1% 447.0% 129.0% 43.9% -22.61% -20.36% 13.7% 30.9% 158.2% -58.58% 6.9%
Marża brutto -21303.33% -7020.43% -1818.21% -711.37% -864.36% -1084.96% -1229.84% -3.04% -47.18% -85.90% -18.05% 20.7% -2.59% 14.8% -7.67% -115.60% -5.60% 9.1% 53.7% -183.62% -48.04%
Koszty i Wydatki (mln) 18 18 23 28 33 43 49 67 61 74 76 75 82 93 110 120 110 115 124 188 206
EBIT (mln) -18 -18 -22 -26 -30 -41 -46 -65 -56 -66 -63 -61 -70 -82 -100 -109 -96 -101 -98 -184 -191
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 66.2% 124.7% 106.5% 153.9% 83.6% 61.7% 34.8% -6.12% 24.8% 23.5% 59.1% 79.0% 37.9% 23.0% -1.20% 68.4% 98.6%
EBIT (%) -30571.67% -9794.09% -2607.19% -1002.78% -1219.36% -1637.16% -1856.08% -2598.40% -1056.44% -864.90% -479.38% -445.91% -575.78% -741.78% -985.45% -1002.02% -698.42% -697.39% -377.10% -4073.78% -1297.85%
Przychody fiansowe (mln) 0 0 0 0 0 0 0 0 0 1 2 4 5 5 5 5 4 3 4 5 0
Koszty finansowe (mln) 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0
Amortyzacja (mln) 1 1 1 2 1 2 3 3 3 3 5 5 6 8 8 16 7 8 7 13 0
EBITDA (mln) -17 -17 -22 -24 -29 -39 -45 -62 -53 -63 -55 -52 -60 -69 -85 -94 -85 -90 -88 -165 -191
EBITDA(%) -28643.33% -9230.65% -2502.44% -956.29% -1162.64% -1542.76% -1757.80% -2598.40% -1003.93% -820.07% -440.08% -445.91% -507.50% -741.78% -845.52% -858.64% -644.77% -641.90% -337.11% -3665.33% -1297.85%
NOPLAT (mln) -18 -19 -24 -26 -31 -43 -47 -65 -56 -66 -60 -57 -65 -77 -93 -95 -92 -98 -96 -179 -203
Podatek (mln) 0 1 1 -0 0 2 1 0 -0 -0 -2 -0 -5 -6 2 -2 -1 -1 0 0 -0
Zysk Netto (mln) -18 -19 -24 -26 -31 -43 -47 -65 -56 -66 -58 -57 -61 -77 -93 -93 -91 -98 -96 -179 -202
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 66.7% 129.1% 98.7% 152.0% 82.2% 51.0% 23.0% -11.48% 8.6% 17.1% 59.5% 61.8% 50.3% 27.1% 2.9% 92.4% 121.6%
Zysk netto (%) -30706.67% -10184.41% -2769.49% -1010.04% -1228.68% -1736.04% -1897.12% -2597.32% -1056.37% -856.47% -446.77% -420.29% -500.98% -696.50% -920.78% -853.88% -662.41% -676.56% -366.82% -3965.99% -1373.26%
EPS -0.1095 -0.1125 -0.1416 -0.15 -0.1825 -0.2577 -0.28 -0.38 -0.33 -0.38 -0.34 -0.31 -0.32 -0.38 -0.43 -0.4 -0.39 -0.4 -0.34 -0.53 -0.5
EPS (rozwodnione) -0.1095 -0.1125 -0.1416 -0.15 -0.1825 -0.2577 -0.28 -0.38 -0.33 -0.38 -0.34 -0.31 -0.32 -0.38 -0.43 -0.4 -0.39 -0.4 -0.34 -0.53 -0.5
Ilośc akcji (mln) 168 168 169 167 168 168 169 169 171 172 173 186 192 201 214 233 236 242 283 336 403
Ważona ilośc akcji (mln) 168 168 169 167 168 168 169 169 171 172 173 186 192 201 214 233 236 242 283 336 403
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD